Utah Retirement Systems Neurocrine Biosciences Inc Transaction History

Utah Retirement Systems

  • $9.97 Billion
  • Q3 2025

A detailed history of Utah Retirement Systems transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Utah Retirement Systems holds 15,981 shares of NBIX stock, worth $2.32 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
15,981
Previous 16,302 1.97%
Holding current value
$2.32 Million
Previous $2.05 Million 9.52%
% of portfolio
0.02%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$123.98 - $146.67 $39,797 - $47,081
-321 Reduced 1.97%
15,981 $2.24 Million
Q2 2025

Aug 14, 2025
SELL
$87.54 - $128.18 $24,598 - $36,018
-281 Reduced 1.69%
16,302 $2.05 Million
Q4 2024

Feb 14, 2025
BUY
$111.62 - $139.44 $11,162 - $13,944
100 Added 0.61%
16,583 $2.26 Million
Q2 2024

Aug 14, 2024
SELL
$130.86 - $143.19 $26,172 - $28,638
-200 Reduced 1.2%
16,483 $2.27 Million
Q3 2023

Nov 14, 2023
BUY
$94.02 - $117.1 $9,402 - $11,710
100 Added 0.6%
16,683 $1.88 Million
Q2 2023

Aug 14, 2023
SELL
$89.53 - $104.87 $17,906 - $20,974
-200 Reduced 1.19%
16,583 $1.56 Million
Q4 2022

Feb 15, 2023
SELL
$106.72 - $127.06 $21,344 - $25,412
-200 Reduced 1.18%
16,783 $2 Million
Q3 2022

Nov 14, 2022
BUY
$92.03 - $107.81 $27,609 - $32,343
300 Added 1.8%
16,983 $1.8 Million
Q1 2022

May 13, 2022
SELL
$72.45 - $94.81 $21,735 - $28,443
-300 Reduced 1.77%
16,683 $1.56 Million
Q3 2021

Nov 16, 2021
SELL
$86.18 - $99.03 $68,944 - $79,224
-800 Reduced 4.5%
16,983 $1.63 Million
Q2 2021

Aug 16, 2021
BUY
$89.43 - $102.27 $8,943 - $10,227
100 Added 0.57%
17,783 $1.73 Million
Q1 2021

May 17, 2021
SELL
$87.57 - $119.4 $70,056 - $95,520
-800 Reduced 4.33%
17,683 $1.72 Million
Q4 2020

Feb 16, 2021
BUY
$86.91 - $108.33 $69,528 - $86,664
800 Added 4.52%
18,483 $1.77 Million
Q3 2020

Nov 16, 2020
BUY
$96.16 - $135.15 $19,232 - $27,030
200 Added 1.14%
17,683 $1.7 Million
Q2 2020

Aug 13, 2020
BUY
$85.09 - $130.36 $25,527 - $39,108
300 Added 1.75%
17,483 $2.13 Million
Q3 2019

Nov 14, 2019
BUY
$83.82 - $101.5 $8,382 - $10,150
100 Added 0.59%
17,183 $1.55 Million
Q2 2019

Aug 14, 2019
BUY
$72.24 - $91.27 $7,368 - $9,309
102 Added 0.6%
17,083 $1.44 Million
Q1 2019

May 15, 2019
BUY
$69.31 - $91.53 $26,407 - $34,872
381 Added 2.3%
16,981 $1.5 Million
Q4 2018

Feb 08, 2019
BUY
$68.32 - $124.36 $6,831 - $12,436
100 Added 0.61%
16,600 $1.19 Million
Q1 2018

May 15, 2018
BUY
$75.88 - $92.43 $15,176 - $18,486
200 Added 1.23%
16,500 $1.37 Million
Q4 2017

Feb 14, 2018
BUY
$58.53 - $77.59 $17,559 - $23,277
300 Added 1.88%
16,300 $1.27 Million
Q3 2017

Nov 13, 2017
BUY
$47.97 - $61.28 $767,520 - $980,480
16,000
16,000 $980,000

Others Institutions Holding NBIX

# of Institutions
730
Shares Held
102M
Call Options Held
230K
Put Options Held
477K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Utah Retirement Systems Portfolio

Follow Utah Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email